This rich, creamy lather removes dirt and impurities without stripping the skin, helping to even out skin tone and leave your face and body feeling soft, smooth, and radiant
The 30% AHA group peels (Glycolic, Lactic, Kojic, Mandelic) are safe for all skin tones and have a mild strength
Proposed Escalation Strategy A theoretical cagrilintide and retatrutide combination protocol might follow this gradual escalation approach: Weeks 1-4: Foundation Phase Cagrilintide: 0.6 mg weekly Retatrutide: 2 mg weekly Focus: Establishing tolerance to both compounds Monitoring: Gastrointestinal effects, appetite changes Weeks 5-8: Escalation Phase Cagrilintide: 1.2 mg weekly Retatrutide: 4 mg weekly Focus: Increasing receptor activation Monitoring: Weight changes, metabolic markers Weeks 9-12: Optimization Phase Cagrilintide: 2.4 mg weekly Retatrutide: 8 mg weekly Focus: Approaching therapeutic targets Monitoring: Comprehensive metabolic assessment Weeks 13+: Maintenance Phase Cagrilintide: 3.0-4.5 mg weekly Retatrutide: 8-12 mg weekly Focus: Sustained metabolic effects Monitoring: Long-term safety and efficacy This graduated approach mirrors the successful strategies used in cagrilintide 10mg research protocols, where slow escalation minimizes side effects while building therapeutic benefit
MEET THE PURSUIT TEAM RON MILLER, DPT, OCS, Cert DN Doctor of Physical Therapy | Board Certified Orthopaedic Physical Therapy Clinical Specialist | Post-Doctoral Orthopaedic Residency Trained | Certified in Dry Needling | Titleist Performance Institute Certified Dr
What not to layer with copper peptides
